A detailed history of Alphabet Inc. transactions in Alector, Inc. stock. As of the latest transaction made, Alphabet Inc. holds 175,866 shares of ALEC stock, worth $327,110. This represents 0.06% of its overall portfolio holdings.

Number of Shares
175,866
Previous 175,866 -0.0%
Holding current value
$327,110
Previous $798,000 2.88%
% of portfolio
0.06%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Nov 14, 2022

SELL
$14.17 - $20.3 $306,199 - $438,662
-21,609 Reduced 10.94%
175,866 $3.03 Million
Q3 2019

Nov 14, 2022

SELL
$14.42 - $22.2 $14.1 Million - $21.7 Million
-977,065 Reduced 83.19%
197,475 $2.85 Million
Q1 2019

Nov 14, 2022

BUY
$15.97 - $22.5 $18.8 Million - $26.4 Million
1,174,540 New
1,174,540 $22 Million

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $154M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Alphabet Inc. Portfolio

Follow Alphabet Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alphabet Inc., based on Form 13F filings with the SEC.

News

Stay updated on Alphabet Inc. with notifications on news.